Stocks in play: Burcon NutraScience Corp

Announces it has successfully completed end-to-end validation trials of its novel sunflower protein process using commercial-scale equipment at Burcon's Winnipeg Technical Centre. Burcon has validated that its innovative sunflower protein process is robust and ready for commercial scale-up. Burcon's sunflower protein isolates are greater than 90% pure protein, have a neutral flavor profile and are white in color allowing incorporation into many plant-based foods. Initial feedback on Burcon's novel sunflower protein isolate has been overwhelmingly positive. Burcon NutraScience Corp shares T.BU are trading down one cent at $0.23.

Read:

• Global Lithium Supply Under Pressure as South American Nations Discuss "Lithium OPEC"

• International Lithium Buyers Looking to South America to Fill Supply Gaps

• Race to Secure Critical EV Battery Metals Ahead of Chinese Dominance Fully Underway

• Help is on the Way as Rising Alzheimer’s Cases Highlight Urgency for New Treatments

• FDA’s Wave of Fast Track Designations Pushing Momentum in Healthcare Sector in 2023